John Murphy, M.D., Joins NavaDerm as CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Mizuho Securities Reiterates Buy Rating on Humana (HUM) Following 3Q Beat
November 7, 2019 6:52 AM ESTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $316.00 price target on Humana (NYSE: HUM) following the company's 3Q earnings release. HUM reported 3Q results with a beat on adjusted EPS, revenue and adjusted operating profit. Adjusted EPS of $5.03 beat guidance of $4.58. Total... More
